ALSO NOTED: Schering terminates NexMed deal; Rubin resigns from Critical Therapeutics; and much more...

> Schering has terminated its licensing and distribution deal with NexMed for Alprox-TD, an experimental drug for erectile dysfunction. Report

> Chutes & Ladders: Paul D. Rubin has resigned as CEO of Critical Therapeutics. Report

> Chutes & Ladders: Auxilium Pharmaceuticals of Malvern, PA has named Armando Anido as its new president and CEO. Interim president Gerri Henwood resigned to pursue other opportunities. Report

> And Finally… A mystery is developing over whether or not China has concealed the death of a man three years ago from avian flu. Article